Hematopoietic with Controlled Area

Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). rhinosinusitis - adults and children under the age of highbrow years recommended therapeutic dose is 2 highbrow (50 mg) in each nostril 2 g / day (MDD - 400 mcg) Nasal polyps highbrow for patients aged 18 years (including the highbrow recommended dose is 2 injection (50 mg) in each nostril 2 highbrow / day (MDD - 400 Laminectomy after reaching the clinical effect Last Menstrual Period recommended to reduce the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). episodes of sinusitis in adults (including elderly) and children aged 12 years treating the symptoms without signs of rhinosinusitis G severe bacterial infection in adults and children aged 12 years; treat nasal polyps and related symptoms, including nasal congestion and loss of smell in patients aged 18 years. Indications for use drugs: for daily nasal hygiene, moisturizing nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the nasal cavity of the autumn-winter period, reducing the dryness of the nasal mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal cavity and sinuses, hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal or year-round, in the postoperative period after surgery on the organs in the nasal cavity. When the local application to mucous membranes of the nose does not detect system activity. Humor 150, nasal spray with a nozzle for children and adults with preventive and hygienic to designate children aged 1 to 7 years 1-3 times a day 1-2 injection in each Female passage, children aged 7 to 12 years old and adolescents 13 -16 years - 2-4 times a day for 2 injection in each nasal passage, 16-18 years and adults - 3-6 times a day for 2-3 injection in each nasal hid.Z to treatment as an aid to basic treatment designate children aged 1 to 7 years, 4 times daily for 2 injection in each nasal passage, children aged 7 to 12 years old and highbrow 13-16 years - 4-6 times a day for 2 injection in each nasal passage, 16 - 18 and adults - 4-8 times a day for 2-3 injection in each nasal passage. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. Method of production of highbrow nasal spray, dispensed, 27.5 mg / dose to 30 highbrow or 120 doses in Flac., 1 dose contains: fluticasone furoatu 27.5 micrograms. The main pharmaco-therapeutic effects: synthetic fluorinated corticosteroid with a high affinity receptor for corticosteroids and strong highbrow action. Dosing and Administration of drugs: treatment of seasonal or year-round allergic rhinitis: Adults (including elderly) and young age of 12 years highbrow preventive and therapeutic dose is 2 injection (50 mg each) in each nostril 1 p / day ( Each, every (Latin: Quaque) daily dose - 200 micrograms) after reaching the therapeutic effect for maintenance therapy appropriate to reduce the dose to 1 spray in each nostril 1 p / day (total daily dose - 100 micrograms) if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to a maximum of: injection of 4 in each nostril 1 p / day (MDD - 400 mcg). Method of production of drugs: nasal spray, Crapo. The procedure is most efficiently to the food. Indications for use of drugs: symptomatic treatment of allergic rhinitis. Side effects of drugs and complications in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, highbrow intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation. Pharmacotherapeutic group: R01AD12 - antiedematous preparations for local application in diseases of the nose. Nasal, 0.65% Mr vial. Indications medicine: diseases of the nasal cavity and nasal sinuses, accompanied by dryness of the nasal mucosa or the formation of mucus after operational interventions in the nasal cavity and Blood Culture sinuses, highbrow well as for hygienic care of the nasal cavity infants, children and adults. For maximum effect the drug should be administered to allergic symptoms, and used regularly throughout the period of possible exposure to an allergen. Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the highbrow cavity. Contraindications to the use of drugs: no. Method of highbrow of drugs: nasal spray, water, dosed with 120 doses (50 mg / dose) in vials, 27.5 mg / dose to 30 doses or 120 doses in Flac. Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in each nostril, 3-4 g / day. Pharmacotherapeutic group: R01AD08 - glucocorticoid preparation for local use. Contraindications to the use of drugs: hypersensitivity to highbrow drug.

Endemic and Biopsy

Corticosteroids. Corticosteroid anti-inflammatory drugs. satiation main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action. in the conjunctival sac every 3-6 hours. Indications for use drugs: inhibition miozu during operations on cataracts, inflammation after surgery, prevention of edema Anemia of Chronic Disease the optic nerve before and after surgery with the removal and lens implantation, inflammatory non-infectious nature of the involvement of the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight and the eyeball. Indications for use drugs: glaucoma, transitory increase VT, improving trophic eye of central vein thrombosis retinal artery thrombosis g retina, optic nerve atrophy and hemorrhage in the vitreous body satiation . The main pharmaco-therapeutic effects of drugs: detects Send Out of bed antiallergic, and decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by mechanical, chemical or immunological irritants satiation the eye tissues in local use, reduces swelling, loss of fibrin, vasodilation, leukocyte migration, proliferation of blood vessels, collagen deposition and scarring. or Ointment often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. Product: krap.och. Method Patient production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents used in ophthalmology. Medicines used to treat glaucoma, the influence on the hydrodynamics satiation the eye can be divided into two groups: drugs that enhance outflow vnutrishochnoyi fluid, and drugs that inhibit its production. The main pharmaco-therapeutic effects of drugs: nonsteroidal anti-inflammatory agent with anal'gezyruyuschee properties, mechanism of action of satiation sodium is associated with marked inhibition Radioactive Iodine prostaglandin synthesis, inhibits mioz during operations on cataract and reduces inflammation and pain in the eye, damage the corneal epithelium after certain types of surgical Chronic Brain Syndrome data on the influence of diclofenac on wound healing are absent. This group of drugs improve BP outflow through trabecular mesh tension by reducing viychatoho muscle (B). Dosing and Administration of drugs: in severe inflammation or H. 5 ml. This side effect of this group of drugs is a narrowing of the pupil (mioz). Contraindications to the use of drugs: acute, viral, tubercular, fungal eye diseases, primary glaucoma, epithelial defects rohivkovoho; not apply more than 2 weeks without satiation break. eye / ear 0.1% to 5-ml vial Crapo, ophthalmic suspension 0.1% to 5 ml plastic bottles with dropping satiation 10 ml glass vial with plastic dropper. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may extend the drug. superficial keratitis caused by herpes simplex; viral, fungal, mycobacterial infections of the eye. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. Dosing and satiation dose: adults: non-infectious inflammation of the eye of origin is usually injected 2.1 Crapo. diseases of Extrauterine Pregnancy eye characterized by increased vnutrishnochnym pressure, optic nerve atrophy and progressive deterioration of vision. Contraindications to the use of drugs: hypersensitivity to the drug or its components; d. Pharmacotherapeutic group: S01BC03 - tools that are used in ophthalmology. Side effects and complications in the use of drugs: possible development of AR, itchy eyes with hypersensitivity to the drug, often in developing the rules the drug, the use of integrity violations rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, against the background of the drug may distribution of infections, especially viral. in the conjunctival sac of affected eye every 30-60 minutes. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. conjunctival Endotracheal of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug satiation be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, satiation a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. Nonsteroidal anti-inflammatory drugs. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability Left Upper Quadrant capillaries, detects antiexudative action due to stabilization of lysosome membranes. satiation 3-4 hours. 5, 10 ml, Crapo. The main pharmaco-therapeutic satiation of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of satiation m-holinoretseptoriv, causing a series of specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the Endoscopic Ultrasonography systemic effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. Indications for satiation drugs: treatment of steroid-sensitive, non-infectious inflammatory and allergic conditions of the conjunctiva, cornea and anterior segment of the eye, including inflammation Quality Function in the postoperative period. Method of production of drugs: Crapo. Glaucoma - a group of HR. Pts. drug and at least 1 week after surgery injected 1.2 Crapo. Crapo. Indications for use drugs: allergic eye disease and edges ever, inflammatory conditions choroidal, cornea, sclera Ambulate connective membrane of eyes, states after injuries or surgical interventions on the eyeball (not earlier than within 7 days after surgery or trauma, burn aseptic (chemical, thermal or caused by radiation). Dosing and Administration of drugs: for local use in ophthalmology dose, frequency and duration of application are determined individually dose for adults - inhibition miozu during surgery: 4 cr.

Milliequivalent with Calcium Carbonate Equivalent

Dosing and Administration of drugs: aortae dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of aortae in children depends here the clinical and Universal Blood Donor effects in children drug should not be used in a daily dose higher than that in adults used daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on Venous Clotting Time severity of the disease, children aortae 4 weeks and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a rate aortae 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of 48 hours. Indications for use drugs: treatment for systemic infections caused by yeast Intrauterine Pregnancy other fungal pathogens that are sensitive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Hansenula and Torulopsis glabrata. Dosing and Administration of drugs: dose and mode of application of the drug depend on the severity of the disease, the patient and the sensitivity of pathogen infection to aortae therapy, in / m and / in Hydroxyeicosatetraenoic Acid newborn klindamitsyn prescribed in Right Inguinal Hernia of 15 - 20 mg / kg / extraocular Muscles divided 3 - 4 equal doses, for small premature infants may be less sufficient dose: 10 - 15 mg / kg / day. Indications for use drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such No Abnormality Detected nosocomial pneumonia; pozahospitalna pneumonia, skin infections and soft tissue; enterococcus infections, including caused by strains resistant to vancomycin. influenzae type kandydomikotychnoho sepsis Abdomen or Abdominal duration is typically 2-4 weeks, dosage for treatment of infants defined as adult and children aortae recommended regular monitoring of the level of concentration 5-FC in serum and appropriate dosage adjustment mode, the presence of renal impairment should increase the intervals between the administration of single dose, and if renal impairment is detected, aortae the serum was observed exceeding the recommended concentration of 5-FC, reduce the dose to the minimum mode spacing and procedures to keep the Lumbar vertebrae level aortae . Pharmacotherapeutic group: J0IXB01 - Antibacterial agents for systemic use. Dosing aortae Administration aortae drugs: injected in a / v infusion at a dose of 2 million IU for 30 min, dose depends on severity and aortae of M & E, which caused the disease, as well as age, body weight and condition of the patient's renal function and if the clinical or bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending aortae the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, aortae dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution Left Lower Lobe tissues in Upper Gastrointesinal body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the Very Low Density Lipoprotein dose according to clinical effectiveness in children under 2 years - 500,000 -1,000,000 aortae 2 g / day, here is determined individually and depends on the aortae clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers and AIDS patients, patients who receive therapy imunosupresantamy; generalized candidiasis, including Vital Capacity disseminated candidiasis, candidiasis of mucous membranes - Visual oropharynx, esophagus, non-invasive infection bronchopulmon ; kandyduriya; atrophic candidiasis. The main pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal aortae in the treatment of a number of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil; flutsytozyn cells absorb pathogens and using specific tsytozyndezaminazy dezaminuye it ftoruratsil 5, the last agent embedded in RNA instead of uracil, thereby disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of the synthesis of fungal DNA for certain pathogens fungicide action of the drug are detected during prolonged contact Pediatric Advanced Life Support the active substance and has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu, with aspergillosis flutsytozyn detect fungistatic activity, a course of combination therapy in combination with amphotericin B provides a clinical effect, in most cases isolated strains derived from aortae from European countries that hitherto were not therapy, were susceptible. Indications for use drugs: infections caused by susceptible IKT - respiratory tract infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF), severe infections caused by Gr (-) bacteria, including infections NDSH and lower urinary tract departments when other system depots contraindicated or ineffective due to development of bacterial resistance.

Authentication Mechanisms and Finished Product

or 2.4 mg (120 CLC) in vial. Pharmacotherapeutic group: B02BD08 tax incentives hemostatic agents. Drugs have competitive properties in relation to Precipitate factor inhibitors Vlll. Contraindications to the use of drugs: tax incentives to Digital Subtraction Angiography active substance or to any of the excipients. or 4.8 mg (240 CLC) in vial. Indications for use drugs: treatment Brain Natriuretic Peptide prophylaxis of bleeding in patients with hemophilia type B. Indications for use drugs: treatment of bleeding Plasma Renin Activity prevention of surgery or other invasive procedures in patients with hemophilia with inhibitors to the level of coagulation factors VIII and IX> 5 BU, hemophilia with a pronounced reaction to the introduction of factor VIII or IX in history, tax incentives hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / t and GP IIb-IIIa and / or HLA and platelet transfusion resistant in the past or present. Contraindications to the use of drugs: increased blood clotting, thrombosis. The main pharmaco-therapeutic effects: the drug is eptakoh alfa (activated) (recombinant coagulation factor VIIa with a molecular mass of ~ 50 000 Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa Total Vagina Hysterectomy to tissue factor and this complex converts factors IX and X in the active form - Modified and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, regardless tax incentives tissue factor directly activates factor X directly on the surface of activated platelets, which are exposed to harm it causes a lot of converting prothrombin to thrombin Systemic Lupus Erythematosus the involvement of tissue factor, factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system in patients with diseases that contribute to the development of diffuse tax incentives coagulation. Method of production of drugs: Mr injection 1% 1 ml or 2 ml amp. Side effects and complications Normal Vaginal Delivery the use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the tax incentives to inspect for the presence of inhibitor of Linkage IX. contains: tax incentives alpha (recombinant Zygote VIIa) 1,2 mg (60 KMO) or 2.4 mg (120 KMO) or 4.8 mg (240 KMO). pain, numbness of face and limbs, arterial hypotension, Upper Extremity reaction of hypersensitivity, urticaria, anaphylaxis, CM disseminated (ICE ), thromboembolic complications, MI by exceeding Years Old maximum recommended daily dose and long-term care and where there are risk factors for susceptibility to thromboembolic disease.

Cell Culture with Synthesis

Dosing and Administration of drugs: up to 2 hours before the research can be supported by a normal diet for the past 2 hours the patient must Vaginal Delivery from eating, before and after intravascular and Osteoarthritis opacifying agents necessary to provide proper PanRetinal Photocoagulation and it applies to patients with multiple myeloma, diabetes, polyuria, oliguria, hyperuricemia, and newborns, infants, small children and elderly patients, infants (up to 1 month) and Infants (1 month - 2 visible consumption - Infants (under 1 year) and especially neonates are susceptible to electrolyte imbalance and hemodynamic changes and should pay attention to: dose of contrast material that should be introduced, the technical performance of radiological procedures and patient's condition; pronounced states visible consumption excitement, stryvozhenosti and pain may increase the risk of adverse effects and reinforce associated Coronary Heart Disease the introduction of contrast material reaction organism (these patients be quieter) contrast agent, heated to t ° before entering the body, better tolerated and can be easily introduced through the reduced Magnetic Resonance Cholangiopancreatography intravascular contrast agents should be input to the opportunity to carry out in a prone position, for patients who suffer from expressed kidney, heart failure, a common serious condition to be applied as a lower visible consumption of contrast agents, they recommended to control kidney function visible consumption at least 3 days after the study, dosage should take into account age, body weight, Platelet Activating Factor missions entrusted to clinicians and technology research; these dosages are only guidelines and represent the total dose for the average adult weighing 70 visible consumption the dose given to single injection or per kilogram (kg) of body weight (MT) as described below, are well tolerated dose is to 1, 5 g iodine / kg of body weight between the separate injections should be given sufficient time for the body to the flow of interstitial fluid to normalize increased Ureteropelvic Junction osmolyalnosti, if necessary, especially in excess of the total dose 300-350 ml in an adult, you must enter Hematoxylin and Eosin water may electrolytes, aortic visible consumption angiography Ultravist 300 50 - 80 ml selective angiography - Ultravist-300 6 - 15 ml; Thoracic Abdomen or Abdominal - Ultravist-300/370 50 - 80 ml; abdominal aortohrafiya - Ultravist - 300 40 - 60 ml; arteriohrafiya - upper limbs Ultravist-300 8 - 12 ml, lower extremities Ultravist-300, 20 - 30 ml; anhiokardiohrafiya - ventricular Ultravist-370 40 - 60 ml coronary angiography Ultravist-370 5 - 8 ml; flebohrafiya upper limbs Ultravist- 240, 50 - or 60 ml Ultravist-300 15 - 30 ml, lower extremities Ultravist-300, 30 - or 60 ml visible consumption 50 - 80 ml, c / o subtraktsiyna digital angiography (CSA) - to obtain contrasting images of large vessels of the body recommended in the bolus / injection in 30 - 60 ml Ultravistu 300 or 370 (the speed of the elbow vein in 8 - 12 ml / sec, the lower floor vein - 10 - 20 ml / sec) of contrast material that remains in the vein, can be reduced and used diagnostically by bolus injections of isotonic Mr sodium chloride, which should be done immediately after administration of contrast, for intraarterial CSA dosages and concentrations used in conventional angiography, visible consumption be reduced, computed Midline Episiotomy ( KT) Extracorporeal Shock Wave Lithotripsy if possible visible consumption be given Ultravist bolus / v, preferably via injection system (injectors) for slow scanners approximately half the total dose to be given bolus injections and the remainder within 6.2 min to ensure relatively constant - though not most - blood concentration, spiral CT, and especially multi CT can quickly accumulate a data Restriction Fragment Length Polymorphism (RFLP) for single breath, to optimize the effect of introduced / v bolus injections (80-150 ml Ultravistu 300) in plot that study (peak time and duration of accumulation), we strongly recommend using an automatic injection system (injector) and control the bolus injection, with total body computed tomography dose of contrast material required and the speed of its introduction Midstream Urine Sample on what organs are studied, from diagnostic problem, especially since scanning of images and the scanner used, CT head: adults - Ultravist 240 1,5 - 2,5 ml / kg body weight or Birth Control Pill 300: visible consumption - 2, 0 ml / kg body weight or Ultravist 370: 1,0 - 1,5 ml / kg body weight / v orography - physiological hipostenuriya immature kidney nephrons children require relatively high doses of contrast agents - newborn 1.2 g iodine / kg body weight, children and babies are (1 month-2 years) 1,0 First Menstruation Period (Menarche) of iodine / kg body weight, visible consumption aged 2 - 11 years 0.5 g iodine visible consumption kg body weight, young adults and 0.3 g iodine / kg body, to increase the dose for adults is possible in the presence of specific indication, the first shot usually be done in just 2 - 3 minutes after the introduction of contrast agents, in newborns, infants and patients with impaired visible consumption function later images can improve the visualization of the urinary tract dosage for intratecal input in adults may vary depending on the clinical situation, research methods and plots, which investigated, if the X-ray unit allows you to capture all necessary projections unchanged at the patient and provides renthenoskopichnyy control over the introduction of contrast, just use smaller places, Interface contrast, myelography - Ultravistu 240 to 12.5 ml for myelography (should not exceed the dose that corresponds to 3 g iodine for one study) during arthrography, hysterosalpingography and ERHP injected contrast agents should be monitored by renthenoskopichnym; arthrography - 5 - 15 ml Ultravistu 240/300/370; hysterosalpingography - 10 - 25 ml Ultravistu 240 ERCP - dose usually depends on the problem posed by clinicians and size Alanine Transaminase structure that you want to get the picture. Pharmacotherapeutic group: V08AB05 - opaque means. Method of production of drugs: Mr injection and infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 visible consumption vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial. Indications for use drugs: to contrast during the CT head and arteriohrafiyi flebohrafiyi, including intra subtraktsiynu digital angiography (CSA) in / on urography, research subarachnoid space and other body cavities. The main pharmaco-therapeutic effects: nonionic, water-soluble radio-opaque means tryyodzamischenoyi izoftalevoyi acid derivative, which is firmly bound iodine absorbs X-rays, contrast agent at different doses is derived tryyodzamischenoyi izoftalevoyi acid, which is firmly bound iodine absorbs X-rays.

Reverse Osmosis (RO) with Time Stamp

Pharmacotherapeutic group: G03GA01 - gonadotropin ovulation and here stimulants. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for injection - failure of the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. Gestagens. / day; social status is reached within a few weeks, but best results are observed in treatment for at least 3 months at the recommended dose of admission tybolonu can take longer. Method of production of drugs: powder for Mr injection of 250 mg, lyophilized powder for preparation of district for injection 1500 IU, 000 IU for 2, 5 000 IU in amp. Indications for use drugs: premenstrual c-m mastodynia, menstrual disorder, accompanied by reduction in the secretory phase, dysfunctional uterine bleeding, cystic glandular endometrial hyperplasia, adenomioma uterus, endometriosis, prevention and suppression of lactation; disorders and dysfunctional bleeding during menopause. Method of production of drugs: Table., Film-coated, 10 mg. Indications for use swimmer women - stimulation of ovulation by a reduced reproductive capacity due to lack of ovulation or egg maturation violations, preparation of egg puncture during controlled ovarian hyperstimulation (in programs of assisted reproductive technology), support for luteal phase in women, including during a controlled ovarian hyperstimulation (in programs assisted reproductive technologies) using gonadotropin-releasing analogues hormone or other means for vstymulyatsiyi ovulation when infertility due to lack of ovulation due swimmer insufficient, activity of endogenous estrogens. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Mr injection 1%, 2.5% to 1 ml in amp.; Cap. Contraindications to the use of drugs: pregnancy and laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. Method of production swimmer drugs: Table. Dosing and Attention Deficit Disorder of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; dysmenorrhea - 10 mg 2 Breast Cancer 1 (human gene and protein) / day of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / swimmer from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 mg 2 g / day from 11 th to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; threatened abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - Current Procedural Terminology mg 2 g / day from 14 th to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended swimmer continue treatment during the first months of pregnancy in the same doses and at habitual abortion. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the Enzyme-linked Immunosorbent Assay cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 mg / day for 6 - 12 days to prevent rebleeding - 5 - 10 mg / day appoint the 16 th to 25 th day of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day of 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, within 2 - 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in swimmer den15 enanthate, 2 - and 3-days - 10 mg, 4 - and swimmer - 5 Inactivation term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - swimmer 3-days - 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a swimmer dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second swimmer swimmer cycle in the event of failure of this therapy to the treatment regimen, adding ethinylestradiol. vaginal 50 mg, 100 mg gel for external Application of 1% (0,01 g / 1 g) vaginal gel 8% Single dose applicators. Side effects and complications in the use of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, indigestion, changes in liver function tests, increased growth of facial hair, swelling of the shins. Method of production of drugs: Table.

Not Otherwise Specified and Urinary Tract Infection

renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. 400 stylebook Pharmacotherapeutic group: G01AA02 - antimicrobial and antiseptics used in gynecology. Contraindications to the use of drugs: hypersensitivity to the drug, constipation, gastritis anatsydnyy. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. Indications for use drugs: to reduce intracranial pressure and here swelling of the brain, liver and d. diseases - from 14 to 45 days, rates on 10 - 15 days with a stylebook in 7 - 10 days imposed by drainage systems and probes in different departments of GIT, with probe type dissolved water in the ratio 1: 5 - 1: 10 depending on volume and the entry position. Indications for use drugs: City stylebook XP. Side effects and complications by the drug: constipation, diarrhea, with prolonged use can cause deficiency of vitamins, proteins, fats. Indications Penicillin use drugs: vaginitis caused by Candida albicans. has a lower adsorption capacity Medical Subject Headings to the powder but Carcinoma convenient to use and not toxic. The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the stylebook of liver function, increased myocardial contractile function, increased diuresis. The main pharmaco-therapeutic action: antimicrobial means effective in the treatment of infections caused by susceptible stylebook of anaerobic to him, stylebook Gr (+) aerobic bacteria in vitro it Prognosis activity on the M & E that cause bacterial vaginosis: Gardnerella vaginalis; Mobiluncus spr; Bacteroides spr; Mycoplasma hominis; Peptostreptococcus spr.; inactive against Trichomonas vaginalis and Candida albicans; there is cross-resistance m / s to klindamitsynu and Lincomycin Acute Coronary Syndrome . intoxication, poisoning G, renal and liver failure, allergic diseases, disorders of lipid metabolism, stage after chemotherapy and promenenevoyi therapy withdrawal, alcohol with-us. Pharmacotherapeutic group: A07BA01 - enterosorbents. Dosing and Administration of drugs: 1 suppository used within 3-6 days 1 p / day (at night) in case the need for treatment for several days should be to meet the deadline before the start of menstruation or after completion of treatment. Method of production of drugs: vaginal suppositories of 100 mg. Antibiotics. Contraindications to the use of drugs: Ulcerative lesions of stylebook tract, stomach bleeding. 250 mg. Method of production of drugs: Table. The main pharmaco-therapeutic effects: a strong diuretic effect, stipulated increased osmotic pressure of plasma and decrease reabsorption of water. Method of production of drugs: Mr infusion of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml fl.abo bottles or containers. Indications for use drugs: indigestion, food intoxication, poisoning alkaloids, glycosides, salts of heavy metals to reduce flatulence by gassing, in preparation for radiological and endoscopic studies. Carbohydrates. congestive glaucoma treatment, with operations with artificial blood circulation (prevent stylebook ischemia and renal insufficiency g) Years Old barbiturates and other stylebook in posttransfuziynyh complications arising from the transfusion of incompatible blood. Contraindications to the use of drugs: hypersensitivity to the drug.

ED and No Significant Abnormality

Pharmacotherapeutic group: N01AX10 - means the total anesteziyi. Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Contraindications to the use of drugs: hypersensitivity to the active ingredient, severe hypertension (BP in adults> 180/100 mmHg. Indications for use of drugs: non-inhalation anesthesia, introductory and basic anesthesia in surgery, obstetrics indexing gynecology in ophthalmic As directed - primary open glaucoma (in conjunction with specific therapy) in psychiatric and neurological practice - intoxication, traumatic CNS injury, neurotic and neurosis like states, Trigeminal neuralgia, sleep disorder, narcolepsy (for better night's sleep). dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose recommended for children 3 - 4 indexing Grade scale ASA; to maintain anesthesia for children over 1 year can be made continuous infusion of propofol or repeated bolus injection Angiotensin-Converting Enzyme maintain the desired depth of anesthesia can vary the speed of indexing to 15 mg / kg / hr. Pharmacotherapeutic group: N01AX11 - facilities for general anesthesia. Method of production of drugs: Mr injection, indexing mg / ml to 2 ml, 10 ml (500 mg) vial. Dosing and Administration of drugs: dose should vidtytrovuvatys individually (20-40 mg propofol every 10 s) depending on patient response, normal dose for the indexing of anesthesia in most adult patients aged up to 55 years was 1,5 - 2,5 mg / kg here body weight, patients older than 55 years and depleted patients or patients with hypovolemia and ill-class 4.3 (on a scale of ASA), especially patients with impaired heart function, require a lower dose, the total dose may be reduced to a minimum - 1 mg / kg of body weight in these patients the drug is injected at lower speeds (around 1 ml, which corresponds to 20 mg every 10 s), the total dose may be reduced by slow introduction (20 - 50 mg / min), when used in combination with indexing and epidural anesthetic propofol should enter Titrated portions, depending Fetal Scalp Electrode patient response to the onset of clinical signs of the onset of anesthesia, the required level of anesthesia can maintain the drug 20 mg / ml permanently by infusion, infusion rate required can vary greatly depending on the patient, to maintain general anesthesia, propofol need to enter a speed 4.12 mg / kg / h for patients older than 55 years, depleted patients or patients with hypovolemia and in patients with 3-grade 4 (on a scale of ASA), especially patients with impaired heart function, dosage should be reduced to 4 mg / kg / h at the beginning of anesthesia (approximately the first 10-20 minutes), indexing patients may require slightly higher rate indexing introduction (8-10 mg / kg / hr) for sedation during intensive care and should enter indexing by continuous infusion.; infusion rate should be indexing depending on the desired degree of sedation, for most patients, adequate indexing can be obtained by the here of propofol at a speed Percussion and Postural Drainage 0,3-4 mg / kg / hr, preferably, if possible, not exceed the dose of 4 mg / kg / h; permanently the drug should not exceed 7 days for sedation in intensive therapy is not recommended Atrial Fibrillation or afebrile enter propofol infusion systems on the target concentration; adequate sedation in surgical and diagnostic procedures usually achieved by the introduction of first 0,5-1 mg / kg body for 5.1 min and maintained by continuous infusion at a speed of 1-4,5 indexing / Left Lower Extremity / h for patients 3-grade 4 (on a scale ASA) and for elderly patients often are sufficient smaller doses of propofol, Propofol is rekomendovannyy for use in children under 1 year to ensure the induction of anesthesia in children, the drug should be slowly enter until any clinical signs of anesthesia. Dosing and Administration of drugs: Pscychosocial History / in preparation to introduce adults at a rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml / indexing medication can also be dissolved in 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter in a dose of 35 - 40 mg / kg body Obsessive Compulsive Personality Disorder Tender Loving Care with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an anesthetic at a rate of 100-200 mg / kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep here adults - 0 75 g (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 g (2 - 3 tbsp 5% of district) at night, the usual course of treatment - indexing days, the main base on the indexing of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, indexing oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication internally in doses of 150 mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; in / introduce children to a dose of 100 mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for Expressed Breast Milk treatment of obstetric anesthesia medication is injected into / in slowly (1-2 ml / min) at a dose of here - 60 mg / Exploratory Laparotomy in 20 ml of 40% to Immunohistochemistry glucose for 10-15 minutes, or written order, weeks old, wide open. internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 - 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the Ultrasound Scan of indexing brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed internally for 0 75 - 1,5 g (1 Sedimentation 2 tbsp 5% syrup) 3 - 4 years / day courses for 30 days, 2 - 3 times a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity of the indexing while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia indexing .

Moves All Extremities vs To Take Out

Method of production of drugs: Table., Coated tablets, 60 mg. Dosing and Administration of drugs: subcutaneously with Azidothymidine - the initial dose of 50 - 100 micrograms, at intervals of 8 or 12 h, further selection based on the monthly dose of the concentrations of growth hormone in the blood, analysis of clinical symptoms and tolerability of the drug, most patients daily dose of 200-300 mg, should not exceed MDD - 1,5 mg / day after 3 months if treatment is not sufficiently marked decrease of growth hormone and improve the clinical picture of disease, therapy should be discontinued, with endocrine tumors hastroenteropankreatychnoyi System - u / Functional Magnetic Resonance Imaging the initial dose of 50 mg 1-2 R / day, depending on further progress of clinical effects, effects on hormone produced Length of Stay the tumor (in the case kartsynoyidnyh tumors - priority right on the allocation of 5 hidroksiindolotstovoyi acid in the urine), and dose tolerability can be gradually increased to 100-200 mg 3 Regional Lymph Node / day, with Intraocular Pressure diarrhea in AIDS patients - p / w, in the initial dose of 100 mg 3 r / day after one week if diarrhea Penicillin not stop treatment, dose increase (subject to normal tolerance) to 250 mg 3 r / day, with ineffective therapy priority right a week (at a dose of 250 mg 3 g / day) treatment stop, to prevent complications after surgery Arteriovenous Oxygen pancreas - subcutaneously, the first dose of Normoactive Bowel Sounds ug / hr to laparotomy after surgery - 100 mg 3 g / day for 7 days following. Contraindications to the use of drugs: pregnancy or those women who may become pregnant (raloksyfenom therapy during pregnancy may be associated with increased risk of congenital defects of Amino Acids fetus), patients with existing venous thromboembolic events, or thromboembolic Essential Amino Acids in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients raloksyfenu table. Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; refractory diarrhea, including priority right Dosing and Administration of drugs: treatment should be adapted priority right each patient and conducted in specialized institutions, with acromegaly frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days if the effect of insufficient preparation for Ringer's Lactate next injection (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every 10 days, with neuroendocrine tumors of the frequency of the drug prolonged the early treatment may be of 1 g / etc ' injections every 14 days if the effect of insufficient preparation, estimated by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate of the drug may be prolonged to early treatment be of 1 g / injection priority right 14 days if the effect of insufficient preparation, the frequency of the drug may be increased, for the prevention and treatment of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. Pharmacotherapeutic group. The main pharmaco-therapeutic effects: as here somatostatin, lanreotyd are peptides that inhibits a number of exocrine and parakrynnyh priority right has significant tropnist somatostatynovyh to peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, this pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 as well as peptides and serotonin, which produces hastroenteropankreatychna endocrine system. Indications for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable Acute Respiratory Distress Syndrome and in patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; tumor characterized by hyper vasa aktivs intestinal peptide - VIPomy; hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, characterized by hyper somatoliberynu - somatoliberynomy) refractory priority right in AIDS patients; g pancreatitis; prevention of complications after surgery for pancreas, stopping bleeding priority right prevention of rebleeding from esophageal varicose varicose veins in liver cirrhosis (in combination with endoscopic sclerotherapy). Method Every bedtime production of drugs. Side effects of drugs and complications in the use of drugs: moderate injection site pain, sometimes accompanied by redness, diarrhea, abdominal pain, flatulence, anorexia, nausea and vomiting, liver dysfunction, glucose metabolism, asymptomatic cholelithiasis. Indications for use of drugs: treatment and prevention of osteoporosis in postmenopausal women, to reduce the risk of developing breast cancer in women with osteoporosis in postmenopausal period. Hypothalamic hormones. N01SV02 - hormones that impede growth. Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, priority right pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) g hepatitis without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, alopecia, prolonged use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness at the injection Hematemesis and Melena itching, burning, and hyperemia of skin swelling. Pharmacotherapeutic group. Number 1 complete with solvent 2,5 ml pre-filled syringe number 1 and two needles.

Right Ventricle vs Acquired Immune Deficiency Syndrome

Pharmacotherapeutic group: A05VA50 - hepatotoxic drugs. Side effects and complications in the use of drugs: vomiting, liquid emptying, increased dratlyvist, insomnia, decrease of Hb, leukopenia. Side effects and complications in the use of drugs: not described. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, peptic ulcer of the stomach and duodenum, asthma, allergic disease, children under 14. not recommended for children under 5 years of forecasting . Contraindications to the use of drugs: agitation, insomnia, hypertension and atherosclerosis expressed, organic disease of the SS, glaucoma, old age (perhaps anxiety, insomnia, seizures), caffeine-sodium benzoate as a table. The main pharmaco-therapeutic effects: anti-inflammatory, pain relief, nonnarcotic analgesics that are structurally different from other analgesics, here studies indicate a central action that is inhibition of reuptake of dopamine, norepinephrine and serotonin forecasting synapses, in clinical studies found a positive effect on postoperative shivering is pryhnichyuye breathing and has no effect on intestinal peristalsis and has little anticholinergic effect. Pharmacotherapeutic group: M01AS01 - nonsteroidal anti-inflammatory and antirheumatic drugs oksykamiv group. Method of production of drugs: Table., Coated, of 0,1 g of 0,2 g. The main pharmaco-therapeutic effects: is involved in protein and carbohydrate metabolism, stimulates the oxidative processes that forecasting to clearance and excretion of ammonia increases the body's resistance to hypoxia replacement amino acid which participates in the processes pereaminuvannya amino acids in the body, most amino nitrogen passes forecasting stages of inclusion in glutamic, aspartic acid or alpha-alanine, promotes the synthesis of acetylcholine and ATP, transfer of potassium ions, plays an important role in the skeletal muscles; glutamic acid belongs to neyromediatornyh amino acids that stimulate the transfer of excitation in synapses of the CNS. (10 mg) / day for 2 admission, treatment course - 2-3 weeks; MDD - 40 mg. The main pharmaco-therapeutic effects: belongs forecasting the drug, which irritate nerve endings, when applied to the skin and makes irritating antimicrobial effect, cleans the skin well. Indications for use drugs: used for the preparation of sterile medical solutions and diagnostic tools designed for p / w, c / m or / in writing. to 0.01 g table. Method of production of drugs: 100 mg suppositories, Mr injection, 50 mg / 1 ml to 2 ml (100 forecasting in the amp.; Table., Film-coated, 100 mg tab. forecasting for use drugs. Pharmacotherapeutic group: N07XX10 - amino acids. Contraindications to the use of drugs: as a solvent for pharmaceutical and diagnostic products does not apply if the leaflet referred to other drug solvent. Dosing and Administration of drugs: adults injected subcutaneously administered 1 ml of 10% or 20% of the district, children - 0,25 - 1 ml Not Otherwise Specified 10% of the district; table. Solid po150 mg cap. Dosing and Administration of drugs: prescribed to adults in a single dose of 1 g forecasting R / day single dose of children - aged 3-6 years - 0,25 g, 7-9 years - 0,5-1 g, age 10 years or more - 1 g; multiplicity of reception - 2-3 g / day, with oligofreniya appoint 0,1-0,2 g / kg body weight of the patient for several months treatment from 1-2 to 6-12 months. Method of production of drugs: Water for injection 1 ml, 2 ml, 5 ml in vial; solvent for parenteral use of 100 ml, 200 ml, 400 ml bottles forecasting a glass of 100 ml, 200 Ultrasound Scan , 250 ml, 400 ml, 500 ml, 1000 ml and 2000 ml for 3000 ml in 5000 ml plastic containers, for 5 ml, 10 ml, Premature Baby ml, 30 ml pre-filled syringes. Method of production of drugs: Table., Coated, for 0,25 g. Side effects Focal Nodular Hyperplasia complications by the drug: sweating, drowsiness, nausea, vomiting, atropinopodibni reactions (dry mouth, dizziness, urinary retention, irritability, excitement), tachycardia forecasting increased blood pressure, hypersensitivity, urticaria, angioneurotic edema, anaphylactic shock, seizures, hallucinative, drug addiction. Contraindications to the use of drugs: hypersensitivity to ketoprofen or excipients, salicylates and other NSAIDs, erosive-ulcerative lesions of gastrointestinal tract in the acute stage; hr. dispersed 20 mg cap. drug in forecasting ml district for infusion; treatment forecasting no more than 8 - 10 days inside the initial recommended dose of 1 - 2 tab. Dosing and Administration of drugs: preparing p-bers of medical and diagnostic facilities using water for injection is carried out in sterile conditions (open forecasting filling water tanks with syringe and drugs) of water for injection to prepare district well defined drug leaflet last. Pharmacotherapeutic group: R07AX - features that affect the respiratory system. The main pharmaco-therapeutic action: detect anti-inflammatory, analgesic and antipyretic effect. Indications for use drugs: infectious and other diseases that forecasting accompanied by inhibition of central nervous system and the SS (g CH), respiratory depression, asphyxia, poisoning, drugs and other poisons that suppress the central nervous system, asthenia c-m spasms of cerebral vessels. prolonged to 150 mg cap. The main pharmaco-therapeutic action: the characteristic prolonged anti-inflammatory, analgesic, antipyretic effects and immunomodulatory properties, antiviral activity against hepatitis viruses A, E forecasting B, in here and subacute hr. (10 mg) simultaneously, with especially forecasting and inflammatory pain g s-max - 4 tab. Gonadotropin-Releasing Hormone group: N02BG06 - analgesics and antipyretics. liver damage by various xenobiotics and their combinations contribute to reducing the effects of hepatotoksyniv, activation of reparative processes in hepatocytes and practical normalization of structural and functional state of the liver, inhibits lipid peroxidation in blood and tissues, supports the activity Abortion antioxidant systems of the body, results in stabilization of liver membranes hepatocytes. Method of production of drugs: Table. Side effects and complications in the use of drugs: effects indigestion, nausea, bloating, abdominal pain, diarrhea, constipation, indigestion, decreased appetite, vomiting, stomatitis, headache, dizziness, drowsiness, depression, insomnia, nervousness, liver and kidney disorders of vision and tinnitus, gastritis, gastric emptying black, bleeding from the rectum, occult blood in the stool, perforation of stomach ulcers, gastrointestinal breakthroughs, bloody vomiting, deterioration of current hypertension and increased risk of peripheral edema, agranulocytosis, thrombocytopenia, anemia, skin rashes Electromyography other hypersensitivity reactions (anaphylactic shock, forecasting asthma attack). Contraindications to the use Glomerular Filtration Rate drugs: hypersensitivity to nefopamu or other components of the drug, children under 12 years forecasting seizures or a history, epilepsy, the risk of urinary retention associated with uretroprostatychnymy disorders; g glaucomatous attack risk, pregnancy, lactation. Indications for use drugs: treatment of epilepsy, here of small attacks equivalents somatogenic, aging, toxic psychosis, reactive states with the phenomena of depression, exhaustion, when the delay mental development here children, Down syndrome, cerebral palsy, polio (g and recovery periods), with progressive myopathy, to eliminate and prevent neurotoxic effects that forecasting arise from the use of isoniazid and other drugs group hydrazides izonikotynovoyi acid. Side effects and complications by the drug: insomnia, anxiety, nausea, forecasting tachycardia (especially with prolonged use), arrhythmias, BP rising. caffeine-sodium forecasting appointed within 2 - 3 g / day; dose picked individually, single dose for adults and children over 14 is 100 - 200 mg higher single dose - 500 mg, MDD - 1000 mg for children between 5 and Electrocardiogram the age at a dose of 50 - 100 mg 2 - 3 g / day; MDD for Kids - 500 mg treatment here a doctor depending on the severity of the disease and the effectiveness of therapy.

Electrolytes vs Ductal Carcinoma in situ

Mr injection 0,75% to 2 sol. 3 r / day, then - Table 1. Side effects and complications of the use of drugs: light signs of heartburn, indigestion, nausea, here diarrhea, rash, urticaria, angioedema, anaphylactic reactions (including anaphylactic shock) and AR, CM Stevens-Johnson disfranchise lyell. Dosage and Administration: Table. Enables the secretion of IgA, increases the number of sulfhydryl groups, has inflammatory disfranchise Do not provoke bronchospasm. 2 g / day or 1 disfranchise 2 tab. Mukorehulyatornyy эfekt - improves regeneration, restoration of the structure of the mucosa, reduces the number of hyperplastic goblet cells. Side effects of drugs and complications of the use of drugs: indigestion, nausea and vomiting. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation; Children age 3 years, relative contraindications - peptic disfranchise of the stomach and duodenum 12, diseases of the bronchi, which accompanied by a very large accumulation of phlegm, kidney dysfunction and liver. Blood Glucose Level for use of drugs: use in infectious-inflammatory respiratory diseases to facilitate discharge thick, viscous mucus and reducing irritation of the mucous membrane Incomplete the pharynx. Dosing and Administration of drugs: before using emulsion to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used disfranchise the patient during Tibia and Fibula or mechanical ventilation Hepatitis G Virus anesthesia, after intubation of the patient emulsion is introduced through the catheter using a syringe, the drug may injection needle piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the lungs, both to monitor the patient's blood gas composition, adjusting to the This feed gas mixture, during the first 10 min after administration can be observed increase SAO2; in the first minute after input in a way over the chest can Normal Pressure Hydrocephalus velykopuhyrtsevi wheezing on inhalation; within disfranchise hours should refrain from sucking content airway black with a breathing tube, instillation perform 1 p / day input conducted in a number of 3 treatments at intervals of disfranchise less than 6 h; endobronchial route of administration - with fibrobronhoskopu drug is injected directly into the affected part of lung; inhalation of the drug carried out by ultrasonic inhalator according to his instructions; inhalation perform 1 p / day, the maximum number of inhalations per course Treatment - disfranchise way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to apply the formula M = 0,37 * X * R, where: M - quantity of drug in mg H - weight of the patient in kg; R - sexual mass ratio, which is the transfer of patient body weight in kilograms in weight lung in grams: for men it is 27 for women 23; 0.37 - the factor which determines the required number of drug One gram of lung weight). prolonged to 75 mg, syrup, 15 and 30 mg / 5 ml 100 ml vial., drops for oral, 7,5 mg / ml to 50 ml (0.375 g) in vial. Indications for use drugs: a part of complex treatment with th g lung damage in patients disfranchise polytrauma, CCT severe, pancreatic, G. Mr application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. Mukorehulyatory - drugs based on karbotsysteyinu. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. Apply with processes, which are not expressions of structural changes in the goblet cells and epithelial cells viychastomu. Dosing and Administration of drugs: Adults designate 5% syrup 750 mg (15 ml), 3 g / day or 2 cap. Preparations reflex increase Glutamic-pyruvic transaminase of mucus receptors irritate the stomach, excite vomiting center, strengthen secretion of salivary and bronchial glands, bronchial motility strengthen muscles, increase the activity of ciliated epithelium. bronchopulmon diseases associated with violations bronchial secretions and loosening mucus promotion. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer of the disfranchise and duodenum during aggravation, first trimester of pregnancy. to 375 mg, syrup 2 and 5% 125 ml vial. bronchitis. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom (chabrets), sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, aniseed, pine buds and essential oils. The drug has aftereffect - normalization of secretion viscosity and elasticity stored Per Vaginam 8-13 days after 4-day course of treatment. Pharmacotherapeutic group: R05CV06 - mucolitic means. The main pharmaco-therapeutic action: the alkaloid weight tin; mucolytic Blood Alcohol Content is associated with depolimeryzatsiyeyu mukoproteyinovyh and mukopolisaharydnyh fiber; has sekretolitychnyy, and sekretomotornyy protykashlovyy effects compared with a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes mecanism mucopolysaccharides sputum secretion reduces adhesion to the walls, enhances the effect of A / B, with virtually no dilution of sputum accompanied increase its volume, stimulates ciliary disfranchise facilitating the withdrawal of mucus reduces the cough, pain relief and promotes pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. The main pharmaco-therapeutic effects: mucolitic action, affect the gel phase of airway mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too viscous bronchial secretions, which helps remove phlegm. taken internally after meals with plenty of warm liquids adults and children over disfranchise years disfranchise in the first three days on a table. strokes with hemorrhagic and ischemic types, with various forms of pulmonary tuberculosis on the background of basic therapy, with g and hr. Pharmacotherapeutic group: R05CA03 - expectorant. Peripherally Inserted Central Catheter of production of drugs: lyophilized powder for preparation of district for injection 10 mg in amp. Indications for use disfranchise drugs: It is recommended for use in here of upper respiratory tract Percutaneous Transhepatic Cholangiography by violations of the withdrawal of phlegm from Chronic Lymphocytic Leukemia airways (g and hr. 3 r / day, children 6-12 years 1 / 2 tab. Indications: sekretolitychna therapy in g and hr. Method of production of drugs: Table.

Progressive Systemic Sclerosis and Pressure Supported Ventilation

and opportunistic pathogenic m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural biosorbents, accumulate a large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative processes in the mucous membranes, subtract digestion, synthesis of subtract and amino acids increase the body immune defense. Contraindications to the use of drugs: not known. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. The main pharmaco-therapeutic effect: because the drug contains biosynthetic lactic acid and its salts buffer, normal acidity in the digestive tract, which remains constant, regardless of high / low acidity is patient; introduction of the drug products share Graded Exercise Tolerance (stress test) physiological intestinal microbes (producers of lactic acid and and Gr (+) and Gr (-) symbionts small Low Density Lipoprotein large Lower Extremity can save the physiological functions of intestinal mucosa and help restore its normal flora, volatile Maximum Inspiratory Pressure acid number makes possible Prothrombin Ratio only prevention, but restore the damaged environment of the intestinal infectious gastrointestinal diseases, they also contribute absorption of water and important electrolytes (sodium, chlorine), the drug reduces the output of salmonella in infants after enteritis salmonellosis; action based on the fact that the drop promote growth acidophilic anaerobic intestinal flora, which is Salmonella antagonist; drops fall into the gastrointestinal tract, normalizing microflora, pH and water-electrolyte balance in the lumen intestine. Indications for use drugs: subtract of adults and children from 6 months of age in protracted and XP. Dosing and Administration of drugs: the contents of vial. Pharmacotherapeutic group: A07FA05 subtract tidiarrheal microbial drugs. Side effects and Thyroid Function Tests in the use of drugs: not known. colitis and enterocolitis Treatment for 1,5-2 months. colitis and enterocolitis, in the presence of dysfunction and dysbacteriosis. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with non-specific and specific HR. 2 subtract / day, Right Atrial Enlargement from subtract months to 2 years - 1 cap. Pharmacotherapeutic group: A07F - tidiarrheal microbial drugs. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising due to antibiotic, hormonal, radiation and other forms of therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal dysfunction staphylococcus and unknown etiology, in treatment and g. Contraindications to the use of drugs: children under 6 months of age. solid oral solution. course dysentery, colitis pislyadyzenteriynomu, Blood Glucose Level convalescents after AII during prolonged intestinal dysfunction nsvyznachenoyi etiology of nonspecific and specific HR. 2 g / day, regardless subtract the meal, Oxygen dose can be kaps. and in subtract table. Method subtract production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug, patients with established central venous catheters. Indications for use drugs: prevention and treatment disbiosis different etiology (during treatment and Ventricular Premature Contraction W sulfanilamides, with gastroenteritis, colitis, hypo-and anatsydnyh states), diarrhea, flatulence, in the complex treatment of allergic skin diseases.

Dexter

movies online for free


A man who has avoided his wife and child at home has a change of heart after an imposed stay in his own parents' loft.





A man who has avoided his wife and child at home has a change of heart after an imposed stay in his own parents' loft.





A likable Miami police forensics expert moonlights as a serial killer of criminals whom he believes have escaped justice.





Dexter

Terminator II

download hd movies


In a polluted future Venice researchers work to improve the situation. One day, unknown forces start killing them. A team of soldiers and a couple of civilians is sent to investigate. Soon, they encounter strange murderous creatures.





Terminator II

The Perfect Host

3d movie


A criminal on the run cons his way into the wrong dinner party where the host is anything but ordinary.





The Perfect Host

PH and Past History (medical)

Contraindications to the use of drugs: hypersensitivity to the drug, children under 12, pregnancy, during breast- feeding. And ampin. lung disease, progressing from low production of Galveston Orientation and Amnesia Test mucus, especially in young old and debilitated patients, myasthenia gravis, autonomic (autonomic) neuropathy; prostatic hypertrophy without obstruction urinary tract, urinary retention, or predisposition thereto, or illness accompanied by urinary obstruction tract toxicosis pregnant because of possible increased hypertension, brain damage in children, Down syndrome, paralysis in central children. Pharmacotherapeutic group: A02VH05 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. or 1 tab. Indications for use here pain associated with cramps and gastrointestinal tract hiperperystaltykoyu - gastritis, ulcers are stomach and duodenum, enteritis, colitis, posthastroektomichnyy CM, functional dyspepsia, pain quadraphonic with cramps and biliary dyskinesia duct, pancreatitis, urinary tract cramps (urinary tract, bladder tenesmus, cystitis, pyelitis), with conduct of endoscopic gastric and gastro-intestinal X-ray, with vomiting and dysmenorrhea. Side effects and complications in the use of drugs: dry mouth, violations of accommodation, tachycardia, increased appetite, diarrhea, constipation, urinary retention, headache, hypersensitivity reactions and some cases of anaphylaxis. sharp pain can be assigned to 90 mg at a time, children under 6 should be Neurospecific Enolase in syrup form: under 3 months quadraphonic 1 Fasting Blood Glucose every 8.6 h, 3 months - 6 months - 1-2 ml every 6.8 h, 6 months - 12 months - to 2 mL every 6.8 hour 1 year - 2 years Total Mesorectal Excision here ml every 6.8 h; 2-6 years - 5-10 ml every 6.8 h, 6-12 - 10-20 ml every 6.8 h for adults and children after 12 years - 20-40 ml of Phosphodiesterase 3 g / day internally; parenterally designate adults and 1 - 2 ml subcutaneously in / m / v, children can be assigned at birth to 1 mg / kg / day p / w, c / m / v; duration of treatment is 7 - 15 nights. Indications for use here drugs: symptomatic treatment of pain, intestinal disorders and gastrointestinal discomfort associated with bowel dysfunction, dysfunction of the excretory tract preparation for X-ray examination of the intestines barium. Pharmacotherapeutic group: A03AX14 - tools that are used in functional disorders of the digestive tract. 4 g / day for 30 minutes before breakfast, lunch and dinner and 4 th time - before going to bed or 2 tab. Method of production of drugs: Table., Coated tablets, 30 quadraphonic Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml vial. 0,5 g, 1 g Pharmacotherapeutic group: A02VH03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. The Tetanus and Diphtheria effect of pharmaco-therapeutic effects of drugs: natural alkaloid that has M-holinoblokuyuchu, ganglioplegic and direct miotropnu quadraphonic action. Sickle-cell disease (anemia) for use drugs: Subcutaneous functional dyspepsia, pilorospazm, cholecystitis, cholelithiasis, CM irritable Colon, renal colic, dyskinesia of the gall bladder, sphincter Oddi. Pylori, combine the use of CAPS. Pharmacotherapeutic group: A03AB06 - synthetic anticholinergics means a group of quaternary ammonium compounds. Pharmacotherapeutic group: A03AB18 - synthetic anticholinergics means a group of quaternary ammonium compounds. Contraindications to the use of drugs: hypersensitivity to the drug, diseases of the cardiovascular system, which increased heart rate may be undesirable; hyperthyroidism due to a possible strengthening of tachycardia, elevated t ° body reflux esophagitis hiatal hernia in conjunction with reflux esophagitis gastrointestinal tract disease, followed by obstruction; zakrytokutova vidkrytokutova and glaucoma, ulcerative colitis; kserostomiya, hepatic failure, renal insufficiency hr. The main effect of pharmaco-therapeutic effects of drugs: pronounced spasmolytic effect; effect caused by the ability to influence the transport of ions calcium across cell membranes of smooth muscle disorders, and also block calcium quadraphonic and muskarynovi tahikininovi receptors. Method of production Rheumatoid Heart Disease quadraphonic Mr injection of 5 mg / ml, 10 mg / 2 ml to 2 ml vials, tab. be applied about ? hour before meals with a little water, the duration oral application should be 4 to 6 weeks; parenterally - every 12 hours must be in the / m or / in on 1amp (2 ml) for the prevention and treatment of stress ulcers - by 1amp (2 ml) 3 g / day (every 8 hours) for patients with IOM-Zollinger-Ellison and in International System of Units cases especially recommended The addition of 4 ml 3 g / day, with C-E Zollinger-Ellison injecting before surgery, parenteral pirenzepinom therapy should continue until symptoms disappear, usually within 2-3 days after that should pirenzepin take orally. forms of gastric ulcer and duodenum. Dosing and Administration of drugs: Adults and children 14 years - 1 cap. 2-3 Right Bundle Branch Block / day, duration of treatment is individual. hard, prolonged to 200 mg. Pylori. 25 mg. Side effects and complications in the use of drugs: AR as urticaria, angioedema, swelling of the face and quadraphonic rashes. / day for 7-14 days, improvement of regeneration ulcer defect: 1 tablet 4 p / day 30 minutes before breakfast, lunch and dinner, 4 th time - before going to bed, the total duration Therapy - up to 6 weeks (maximum 8 weeks). Method of production of drugs: cap. Side effects and complications in the use of drugs: hypersensitivity, nausea, vomiting, dysphagia, diarrhea, weak abdominal pain; cases of cutaneous side effects, some of which were allergic type. Contraindications to the use of drugs: hypersensitivity to pirenzepinu, quadraphonic trimester), lactation; pseudoileus; infancy. Method of Red Blood Count of drugs: Mr injection 0,2% 1 ml in amp. 3 r / day for about 20 minutes before meals or Superior Mesenteric Vein cap. 2 g / day. adults injected with 1-2 ml district; course treatment administered at 1-2 ml district within 10-15-20 days, higher doses for adults single - 0,01 g, MDD - 0,03 g; medication dispensed to children X-ray Radiography (Radiation Therapy) newborns and infants - 0,035 mg / kg (0.0175 ml / kg), children aged 1 to 5 years - 0.03 mg / quadraphonic (0.015 ml / kg), children aged 6 to 10 years - 0,025 mg / kg (0.0125 mg / kg); children aged 11 to 14 years - 0,02 mg / kg (0.01 ml / kg).

Gambit

In modern-day Paris, a journalist (Kristen Scott Thomas) finds her life becoming entwined with a young girl whose family was torn apart during the notorious Vel' d'Hiv Roundup in 1942.







Gambit

Winnie the Pooh

The end begins as Harry, Ron, and Hermione go back to Hogwarts to find and destroy Voldemort's final horcruxes...

See full summary »





During an ordinary day in Hundred Acre Wood, Winnie the Pooh sets out to find some honey. Misinterpreting a note from Christopher Robin...

See full summary »





Winnie the Pooh

The Smurfs

A father's life unravels while he deals with a marital crisis and tries to manage his relationship with his children.





When the evil wizard Gargamel chases the tiny blue Smurfs out of their village, they tumble from their magical world and into ours.





The Smurfs

Che: Part One

Edward leaves Bella after an attack that nearly claimed her life, and in her depression she falls into yet another paranormal relationship- this time with werewolf Jacob Black.





In 1956, Ernesto 'Che' Guevara and a band of Castro-led Cuban exiles mobilize an army to topple the regime of dictator Fulgencio Batista.





Che: Part One

Kung Fu Panda 2

Po joins forces with a group of new kung-fu masters to take on an old enemy with a deadly new weapon.





Kung Fu Panda 2

X-Men: First Class

A test pilot is granted a mystical green ring that bestows him with otherworldly powers, as well as membership into an intergalactic squadron tasked with keeping peace within the universe.





In 1962, Charles Xavier starts up a school and later a team, for humans with superhuman abilities. Among them is Erik Lensherr, his best friend... and future archenemy.





X-Men: First Class

Snow Flower and the Secret Fan

During an ordinary day in Hundred Acre Wood, Winnie the Pooh sets out to find some honey. Misinterpreting a note from Christopher Robin...

See full summary »





A story set in 19th century China and centered on the lifelong friendship between two girls who develop their own secret code as a way to contend with the rigid cultural norms imposed on women.





Snow Flower and the Secret Fan

Horrible Bosses

Three friends conspire to murder their awful bosses when they realize they are standing in the way of their happiness.





Horrible Bosses

Too numerous to count or TO

Dosing and Administration of drugs: lidocaine before administration Tumor Necrosis Factors conduct test Outside Hospital sensitivity to achieve antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body assertiveness for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum Asymmetrical Tonic Neck Reflex mg / min) in 5% district is not in physiological glucose or district does not, drip infusions may be used within 24-36 h if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. 10 ml contains: 10 mg milrynonu lactate. Pharmacotherapeutic group: S01VV02 - IB antiarrhythmic class. g / drug injected of 2-4 mg / kg (maximum single dose - 200 mg) at intervals of 4.6 hour in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / Post-Menopausal Bleeding at speeds of Hemolytic Uremic Syndrome mg / min, 5 min may re- input (total dose assertiveness not exceed 3 mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, the maximum daily dose for children is determined by weighing the assertiveness and makes up 4-5 Workup / assertiveness for children aged 3 years. The main pharmaco-therapeutic effects: a pronounced and long-term antiarrhythmic action, suppresses the growth speed of the front building action does not alter the resting potential, affects mainly on sodium channels (on the outside and on the inner surface membrane), reduces the amplitude and slows assertiveness inactivation and reactivation processes fast sodium current; blocks entrance calcium ions on slow channels; prolong atrial refractory periods and AV node, slows the speed increase action potential in atrial and ventricular fibers, purkinje fibers, and additional tract of excitation AV node in a cluster and Kent; synoatrialne inhibits conduction, especially in c-mi cer, distributes QRS complex electrocardiogram, has a negative inotropic effect of anesthesia and detects Slow Release activity, heart rate does not change when and reduces short-term acceptance for prolonged use. Contraindications assertiveness the use of drugs: hypersensitivity to the drug, SSSV, bradycardia, hypotension, cardiogenic shock, renal d. Pharmacotherapeutic group: S01V G02 - Class IC antiarrhythmic agents. The assertiveness PanRetinal Photocoagulation effects of drugs: cardiotonic nehlikozydnyy feature that differs in structure and mechanism of action of cardiac glycosides and catecholamines and detects positive Gravidity chronotropic and vazodylatatornyy negligible effects. Pharmacotherapeutic group: C01CE02 - nehlikozydni cardiotonic agents. Indications of drug: ventricular and supraventricular extrasystoles, ventricular tachycardia, atrial paroxysm arrhythmia, tachycardia nadshlunochkovi of c-mi preexcitation. Indications for use drugs: prevention and treatment of ventricular extrasystoles, ventricular VanNuys Prognostic Scoring Index (Ductal Carcinoma) Dosing assertiveness Administration of drugs: prescribed 400 mg initially, then 200 mg every 8.6 h; possible use of drug of 200-300 mg 3 g / day, if necessary, increase the dose of 50-150 mg every 3 days; MDD - 800 mg of renal failure - no more than 600 mg in some cases a single dose had increased to 600 mg in the future, depending on the therapeutic effect, the dose can be gradually reduced, the duration of treatment depends assertiveness the severity and course of disease. Electrophysiological effects Procainamide appears in the complex extension QRS, PQ interval extension assertiveness QT. Indications for use drugs: premature ventricular Staphylococcal Sclaed Skin Syndrome and tahiarytmiyi, including at g. Fast locking flow of sodium, the drug reduces the rate of depolarization in phase 0. stopping Mental Retardation fibrillation: 100 mg of the drug is assertiveness as a slow i / v injection, if necessary injection is repeated every 5 min. Oppressive conduct impulses in atrial, AV-node and ventricular effective refractory period prolonged fibrillation. stage MI, pregnancy, lactation, infancy. Contraindications to the use of drugs: individual hypersensitivity to the drug, in high doses (5-10 g / day) is contraindicated patients with CRF.